MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
-$3,130,667
EPS
-$0.62
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
1,887,168
1,204,090
1,283,956*
1,143,178
General and administrative
1,329,726
1,677,697
1,186,379.5*
1,846,495
Change in fair value of related party note
0
0
-682,184.5*
193,921
Operating loss
-3,216,894
-2,881,787
-1,788,151*
-3,183,594
Interest income, net
72,884
80,834
96,997.5*
55,151
Other income (expense), net
15,809
58,585
-114,916.5*
240,734
Net loss
-3,128,201
-2,742,368
-1,806,070*
-2,887,709
Foreign currency translation gain (loss)
-2,466
21,490
-42,830.5*
27,204
Comprehensive loss
-3,130,667
-2,720,878
-1,848,900.5
-2,860,505
Basic EPS
-0.62
-0.57
-0.422
-0.65
Diluted EPS
-0.62
-0.57
-0.422
-0.65
Basic Average Shares
5,023,450
4,797,833
4,386,156
4,443,262
Diluted Average Shares
5,023,450
4,797,833
4,386,156
4,443,262
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

INKT Income Statement Sankey DiagramSankey diagram visualizing INKT income statement for the periodComprehensive loss-$3,130,667 (27.10%↑ Y/Y)Net loss-$3,128,201 (26.18%↑ Y/Y)Foreign currencytranslation gain (loss)-$2,466 (95.66%↑ Y/Y)Interest income, net$72,884 (20843.68%↑ Y/Y)Other income(expense), net$15,809 (108.51%↑ Y/Y)Operating loss-$3,216,894 (20.62%↑ Y/Y)Research and development$1,887,168 (2.61%↑ Y/Y)General andadministrative$1,329,726 (-28.09%↓ Y/Y)

MiNK Therapeutics, Inc. (INKT)

MiNK Therapeutics, Inc. (INKT)